Revive Therapeutics Ltd (RVVTF)

$0.03 +0.00 (5.71%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 109,000
Avg Vol 741,736
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 38%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin, which i...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 888-901-0036
Fax: 905-248-3355
Address:
The Canadian Venture Building, 82 Richmond Street East, Toronto, Canada
TarH33ls
TarH33ls Apr. 24 at 11:51 PM
$RVVTF psilocybin reviews fast tracked by FDA. How robust is our psilocybin arm to benefit?
0 · Reply
Tbickle
Tbickle Apr. 24 at 5:26 PM
$RVVTF
0 · Reply
Tbickle
Tbickle Apr. 24 at 5:10 PM
$RVVTF My name is Jose Jimenez. I'm an astronaut. you know the rest.
0 · Reply
Header75
Header75 Apr. 24 at 3:56 PM
$RVVTF
0 · Reply
Canadianbull1324
Canadianbull1324 Apr. 24 at 2:09 PM
$RVVTF the study is done. The patents are pending. News is going to come
1 · Reply
Miswalk1
Miswalk1 Apr. 24 at 1:39 PM
$RVVTF Last PR said, "Following recent discussions with the DRDC, the Bucillamine research study is expected to conclude with results shortly." Says here expected to conclude, with results shortly. Does that mean the study is not yet complete and still being worked on? Wouldn't MF at least have mentioned that the study is now concluded and results will come soon? They don't have to release the results that's fine, but the possibility of the study still happening. How much longer can this possibly take? We know the drdc doesn't care about MF, the company, or shareholders. Im really banking on this stock assuming results were just around the corner. Now I'm not so sure.
1 · Reply
Myturn
Myturn Apr. 23 at 7:17 PM
$RVVTF CEO Michael Frank should confidently engage BARDA—considering DRDC has been evaluating Bucillamine as a potential treatment for: * Nerve agent exposure * Nerve agent–induced brain injury for more than a year, with results pending. This should create an opportunity for U.S. government-backed funding, approval process support, and stockpiling, as soon as positive results are announced by DRDC to move forward toward the next steps!
0 · Reply
Canadianbull1324
Canadianbull1324 Apr. 23 at 2:01 PM
$RVVTF why are we halted
4 · Reply
Dirtymartini66
Dirtymartini66 Apr. 23 at 1:49 PM
$RVVTF not seeing any trades hit yet in US - anything going on in Canada?
3 · Reply
Header75
Header75 Apr. 23 at 1:31 PM
$RVVTF It's time to see substantive monetization around Bucillamine and Psylocybin!
0 · Reply
Latest News on RVVTF
No data available.
TarH33ls
TarH33ls Apr. 24 at 11:51 PM
$RVVTF psilocybin reviews fast tracked by FDA. How robust is our psilocybin arm to benefit?
0 · Reply
Tbickle
Tbickle Apr. 24 at 5:26 PM
$RVVTF
0 · Reply
Tbickle
Tbickle Apr. 24 at 5:10 PM
$RVVTF My name is Jose Jimenez. I'm an astronaut. you know the rest.
0 · Reply
Header75
Header75 Apr. 24 at 3:56 PM
$RVVTF
0 · Reply
Canadianbull1324
Canadianbull1324 Apr. 24 at 2:09 PM
$RVVTF the study is done. The patents are pending. News is going to come
1 · Reply
Miswalk1
Miswalk1 Apr. 24 at 1:39 PM
$RVVTF Last PR said, "Following recent discussions with the DRDC, the Bucillamine research study is expected to conclude with results shortly." Says here expected to conclude, with results shortly. Does that mean the study is not yet complete and still being worked on? Wouldn't MF at least have mentioned that the study is now concluded and results will come soon? They don't have to release the results that's fine, but the possibility of the study still happening. How much longer can this possibly take? We know the drdc doesn't care about MF, the company, or shareholders. Im really banking on this stock assuming results were just around the corner. Now I'm not so sure.
1 · Reply
Myturn
Myturn Apr. 23 at 7:17 PM
$RVVTF CEO Michael Frank should confidently engage BARDA—considering DRDC has been evaluating Bucillamine as a potential treatment for: * Nerve agent exposure * Nerve agent–induced brain injury for more than a year, with results pending. This should create an opportunity for U.S. government-backed funding, approval process support, and stockpiling, as soon as positive results are announced by DRDC to move forward toward the next steps!
0 · Reply
Canadianbull1324
Canadianbull1324 Apr. 23 at 2:01 PM
$RVVTF why are we halted
4 · Reply
Dirtymartini66
Dirtymartini66 Apr. 23 at 1:49 PM
$RVVTF not seeing any trades hit yet in US - anything going on in Canada?
3 · Reply
Header75
Header75 Apr. 23 at 1:31 PM
$RVVTF It's time to see substantive monetization around Bucillamine and Psylocybin!
0 · Reply
LifesGood
LifesGood Apr. 23 at 1:28 AM
$RVVTF
0 · Reply
Myturn
Myturn Apr. 22 at 7:46 PM
$RVVTF Use this link to see the Bid/Ask only in realtime, everything else shown 15 minutes delayed https://www.otcmarkets.com/stock/RVVTF/quote
0 · Reply
Dirtymartini66
Dirtymartini66 Apr. 22 at 6:30 PM
$RVVTF no idea why ST keeps removing my screen shot of bid/ask today - but it's gone again - irritating - it's not like it's controversial - anyway - haven't traded since 12:57pm ET, 197,778 volume - it's 2:29pm ET now - 1 and a half hours - zero trades -
0 · Reply
Dirtymartini66
Dirtymartini66 Apr. 22 at 5:38 PM
$RVVTF not sure why this post isn't showing up but - going to try again -
0 · Reply
Bulldog_Retired
Bulldog_Retired Apr. 22 at 5:14 PM
$RVVTF I will speculate on what is going on, not saying any of this will happen or if it does when it will happen, just speculation: Bucillamine – DRDC study is likely done but now there is an inter-government negotiation occurring on how to fund it, who will buy it (health, defense, emergency preparedness, etc) Psilocybin – RVV has the IP and a safe product tested on other applications (drug addiction, stroke, traumatic brain injury, cancer, and neurological disorders) so it seems a likely partner for a Psilocybin company that is father along in the area of PTSD and therefore a better candidate for a voucher. Also FYI, the US VA has a good write up on Psychedelic-Assisted Therapy for PTSD https://www.ptsd.va.gov/professional/treat/txessentials/psychedelics_assisted_therapy.asp
0 · Reply
Dirtymartini66
Dirtymartini66 Apr. 22 at 4:39 PM
$RVVTF oh hello- got some action - would love to see some heavy volume - 157k as of noon ET - so not bad - this afternoon could be interesting /fun - good luck all
1 · Reply
Mitchz11
Mitchz11 Apr. 22 at 2:04 PM
$RVVTF the waiting game on this is crazy! Hoping for a moonshot. $1+
0 · Reply
Tbickle
Tbickle Apr. 21 at 9:21 PM
$RVVTF
2 · Reply
Canadianbull1324
Canadianbull1324 Apr. 21 at 4:34 PM
$RVVTF DRDC holding back on huge news.
2 · Reply
Barron401k
Barron401k Apr. 21 at 4:08 PM
$RVVTF then mm sent me a message with the 420. Like I'm smoking weed. 😂 Touché! Well played, sir! (I have a medical license, so when this is over, meet me for a nice scotch and I'll exhale for ya!) FAIR VALUE RIGHT NOW: 50¢ MY FORECASTED EOY: $1.20
1 · Reply
Barron401k
Barron401k Apr. 21 at 3:41 PM
$RVVTF 👀 Watch L2. The mm swallowed 30k at .03 but yet the 38k at .03 bid never changed. The 38,682 at .0305 ask will either disappear or magically drift up to the 50k sitting at .04.
1 · Reply
Vectormanic
Vectormanic Apr. 21 at 1:35 AM
$RVVTF Anyone here who got burned by $NUMIF and their saga?
1 · Reply